Examining the Institute of Medicine's Recommendations Regarding Chronic Fatigue Syndrome: Clinical Versus Research Criteria.
Jason, Leonard A, McManimen, Stephanie, Sunnquist, Madison et al. · Journal of neurology and psychology · 2015
Quick Summary
This study compared two different sets of diagnostic criteria for ME/CFS: one proposed by the Institute of Medicine for clinical use, and another (the Canadian criteria) recommended for research. Using patient data from the US, UK, and Norway, researchers found that patients meeting the research criteria were significantly more severely affected across multiple symptoms and daily functioning areas. This suggests the two criteria sets identify somewhat different groups of patients.
Why It Matters
Case definitions directly affect which patients receive diagnoses, access treatment, and qualify for research studies. This study reveals that the criteria used can substantially alter who is identified as having ME/CFS and their apparent disease severity, with important implications for clinical practice, healthcare resource allocation, and research recruitment.
Observed Findings
Patients meeting Canadian research criteria were significantly more impaired on symptom severity measures compared to those meeting only the IOM clinical criteria.
The research criteria group showed greater functional impairment across occupational, educational, social, and personal activity domains.
Differences were consistent across patient samples from the United States, Great Britain, and Norway.
The two criteria sets did not identify identical patient populations, indicating they have different case definition properties.
Inferred Conclusions
The Canadian research criteria may identify a more severely affected subset of ME/CFS patients compared to the IOM clinical criteria.
Case definition choice significantly impacts which patients are classified as having ME/CFS and their apparent disease burden.
International harmonization of ME/CFS diagnostic criteria remains important for consistent clinical and research purposes.
Remaining Questions
Which criteria set better predicts biological markers, treatment response, or long-term outcomes?
Are patients who meet only the clinical criteria but not research criteria a distinct clinical subgroup with different underlying pathophysiology?
What This Study Does Not Prove
This study does not prove which criteria are more accurate or clinically useful—it only documents differences between groups. The cross-sectional design cannot establish causal relationships or explain why the research criteria identified more severely affected patients. It also does not address whether either criteria set captures the biological mechanisms underlying ME/CFS.
How do these criteria sets compare to other proposed definitions (such as those used in other countries or the Systemic Exertion Intolerance Disease designation)?
What is the optimal diagnostic criteria for identifying ME/CFS in clinical practice versus research settings?